Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Símbolo de cotizaciónMGRX
Nombre de la empresaMangoceuticals Inc
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoMr. Jacob D. Cohen
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 21
Dirección15110 Dallas Pkwy, Suite 600
CiudadDALLAS
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal75248
Teléfono18336264679
Sitio Webhttps://www.mangorx.com/
Símbolo de cotizaciónMGRX
Fecha de salida a bolsaMar 21, 2023
Director ejecutivoMr. Jacob D. Cohen
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos